Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omental Islet Transplantation for Type 1 Diabetes
NCT02821026Phase 2Completed
- Sponsor
- University of Alberta
- Start
- May 2016
- Primary completion
- Nov 2019
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of donislecel in type 1 diabetes mellitus (T1D), sponsored by University of Alberta. Started May 2016; status: completed.
02
Drugs
donislecel
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02821026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02821026.